Laura Chico

Stock Analyst at Wedbush

(0.75)
# 2387
Out of 5,370 analysts
259
Total ratings
34.51%
Success rate
-6.35%
Average return
47 Stocks
Name Action PT Current % Upside Ratings Updated
BIIB Biogen
Reiterates: Neutral
121 121
131.07 -7.68% 17 Jun 12, 2025
PHVS Pharvaris
Reiterates: Outperform
27 27
16.62 62.45% 6 Jun 5, 2025
VIGL Vigil Neuroscience
Downgrades: Neutral
13 8
7.87 1.65% 11 May 22, 2025
TVTX Travere Therapeutics
Reiterates: Outperform
30 30
14.73 103.67% 11 May 16, 2025
GOSS Gossamer Bio
Reiterates: Outperform
4 4
1.28 212.5% 5 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
18 17
5.05 236.63% 2 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
17 17
n/a n/a 2 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
4 4
2.31 73.16% 4 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
32 30
14.59 105.62% 8 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
34 26
21.85 18.99% 8 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
26 28
43.77 -36.03% 7 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
43 43
14.66 193.32% 10 Apr 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
42 43
18.96 126.79% 2 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
4 3
n/a n/a 2 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
36 36
18.22 97.59% 6 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 28
5.93 372.18% 9 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
30 29
18.32 58.3% 14 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
6 6
9.06 -33.77% 9 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
157 147
125.3 17.32% 9 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
46 48
37.03 29.62% 12 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
19 12
1.48 710.81% 10 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
22
2.87 666.55% 1 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 44
n/a n/a 7 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 49
32.07 52.79% 8 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
8 7
3.31 111.48% 4 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
11 11
3.67 199.73% 13 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
42 42
15.93 163.65% 7 Jul 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
17 17
11.7 45.3% 6 Jul 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
1435 1435
n/a n/a 3 Jun 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
13 11
n/a n/a 4 Apr 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
5
3.85 29.87% 5 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
330
n/a n/a 6 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
n/a
n/a n/a 5 Sep 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
42
n/a n/a 3 Aug 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
24 5
n/a n/a 2 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 5
2.54 96.85% 2 Aug 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
149
15.15 880.2% 1 Aug 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
16
n/a n/a 1 Sep 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Feb 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
33
n/a n/a 1 Sep 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Outperform
40
n/a n/a 3 Feb 15, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
240 0
n/a n/a 2 Sep 12, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Outperform
36 0
n/a n/a 2 Mar 2, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Jan 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
720
8.68 8194.93% 1 Jan 19, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Nov 16, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Strong Buy
280
22.5 1144.44% 1 Apr 21, 2017